HEADER HYDROLASE 12-MAR-09 2WCG TITLE X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH N-OCTYL(CYCLIC TITLE 2 GUANIDINE)-NOJIRIMYCIN IN THE ACTIVE SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOSYLCERAMIDASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 40-536; COMPND 5 EC: 3.2.1.45; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: DAUCUS CAROTA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4039 KEYWDS LIPID METABOLISM, GLUCOCEREBROSIDASE, MEMBRANE, LYSOSOME, HYDROLASE, KEYWDS 2 GLUCOSIDASE, GLYCOPROTEIN, GAUCHER DISEASE, SPHINGOLIPID METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR B.BRUMSHTEIN,M.AGUILAR,M.I.GARCIA-MORENO,C.O.MELLET,J.M.GARCIA- AUTHOR 2 FERNANDEZ,I.SILMAN,Y.SHAALTIEL,D.AVIEZER,J.L.SUSSMAN,A.H.FUTERMAN REVDAT 4 13-DEC-23 2WCG 1 HETSYN REVDAT 3 29-JUL-20 2WCG 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 15-NOV-17 2WCG 1 COMPND REMARK HET HETNAM REVDAT 2 2 1 FORMUL LINK SITE ATOM REVDAT 1 24-NOV-09 2WCG 0 JRNL AUTH B.BRUMSHTEIN,M.AGUILAR-MONCAYO,M.I.GARCIA-MORENO, JRNL AUTH 2 C.ORTIZ MELLET,J.M.GARCIA FERNANDEZ,I.SILMAN,Y.SHAALTIEL, JRNL AUTH 3 D.AVIEZER,J.L.SUSSMAN,A.H.FUTERMAN JRNL TITL 6-AMINO-6-DEOXY-5,6-DI-N-(N'-OCTYLIMINOMETHYLIDENE) JRNL TITL 2 NOJIRIMYCIN: SYNTHESIS, BIOLOGICAL EVALUATION, AND CRYSTAL JRNL TITL 3 STRUCTURE IN COMPLEX WITH ACID BETA-GLUCOSIDASE. JRNL REF CHEMBIOCHEM V. 10 1480 2009 JRNL REFN ISSN 1439-4227 JRNL PMID 19437524 JRNL DOI 10.1002/CBIC.200900142 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 44184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.138 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2346 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3158 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.71 REMARK 3 BIN R VALUE (WORKING SET) : 0.1660 REMARK 3 BIN FREE R VALUE SET COUNT : 160 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7743 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 188 REMARK 3 SOLVENT ATOMS : 741 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.303 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.201 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.132 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.402 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8158 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11142 ; 1.732 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 984 ; 6.982 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 346 ;36.894 ;23.353 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1218 ;14.364 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;22.291 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1231 ; 0.116 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6168 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4933 ; 0.845 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7956 ; 1.599 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3225 ; 2.714 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3186 ; 4.272 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1509 A 1509 1 REMARK 3 1 B 1508 B 1508 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 14 ; 0.04 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 B (A): 14 ; 0.04 ; 0.05 REMARK 3 TIGHT THERMAL 1 A (A**2): 14 ; 0.27 ; 0.50 REMARK 3 TIGHT THERMAL 1 B (A**2): 14 ; 0.27 ; 0.50 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 5 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 58 3 REMARK 3 1 B 1 B 58 3 REMARK 3 2 A 64 A 311 3 REMARK 3 2 B 64 B 311 3 REMARK 3 3 A 320 A 344 3 REMARK 3 3 B 320 B 344 3 REMARK 3 4 A 351 A 395 3 REMARK 3 4 B 351 B 395 3 REMARK 3 5 A 400 A 497 3 REMARK 3 5 B 400 B 497 3 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 A (A): 1872 ; 0.06 ; 0.05 REMARK 3 TIGHT POSITIONAL 2 B (A): 1872 ; 0.06 ; 0.05 REMARK 3 LOOSE POSITIONAL 2 A (A): 1759 ; 0.10 ; 5.00 REMARK 3 LOOSE POSITIONAL 2 B (A): 1759 ; 0.10 ; 5.00 REMARK 3 TIGHT THERMAL 2 A (A**2): 1872 ; 0.19 ; 0.50 REMARK 3 TIGHT THERMAL 2 B (A**2): 1872 ; 0.19 ; 0.50 REMARK 3 LOOSE THERMAL 2 A (A**2): 1759 ; 0.22 ; 10.00 REMARK 3 LOOSE THERMAL 2 B (A**2): 1759 ; 0.22 ; 10.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1499 A 1502 1 REMARK 3 1 B 1498 B 1501 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 3 A (A): 49 ; 0.06 ; 0.05 REMARK 3 TIGHT POSITIONAL 3 B (A): 49 ; 0.06 ; 0.05 REMARK 3 TIGHT THERMAL 3 A (A**2): 49 ; 0.14 ; 0.50 REMARK 3 TIGHT THERMAL 3 B (A**2): 49 ; 0.14 ; 0.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ALIPHATIC TAIL OF THE INHIBITOR WAS NOT MODELED INTO REMARK 3 THE STRUCTURE. FLEXIBLE REGIONS THAT SHOW NO CLEAR ELECTRON REMARK 3 DENSITY WERE NOT MODELED INTO THE STRUCTURE. REMARK 4 REMARK 4 2WCG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1290038927. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : SILICON 111 CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52146 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.410 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2V3F REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M (NH4)2SO4, 0.1M TRIS PH 6.5, REMARK 280 25%(W/V) PEG3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.41350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -1 REMARK 465 PHE A 0 REMARK 465 ASP A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 THR A 30 REMARK 465 PHE A 31 REMARK 465 LEU A 499 REMARK 465 VAL A 500 REMARK 465 ASP A 501 REMARK 465 THR A 502 REMARK 465 MET A 503 REMARK 465 GLU B -1 REMARK 465 THR B 30 REMARK 465 PHE B 31 REMARK 465 PRO B 32 REMARK 465 LEU B 498 REMARK 465 LEU B 499 REMARK 465 VAL B 500 REMARK 465 ASP B 501 REMARK 465 THR B 502 REMARK 465 MET B 503 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 34 CG CD1 CD2 REMARK 470 GLU A 72 CG CD OE1 OE2 REMARK 470 GLU A 111 CD OE1 OE2 REMARK 470 GLU A 112 CG CD OE1 OE2 REMARK 470 LYS A 155 CE NZ REMARK 470 ARG A 163 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 224 CE NZ REMARK 470 GLU A 300 CD OE1 OE2 REMARK 470 LYS A 441 CD CE NZ REMARK 470 LYS A 466 CE NZ REMARK 470 PHE B 0 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 2 CZ NH1 NH2 REMARK 470 LEU B 34 CG CD1 CD2 REMARK 470 ASN B 59 CG OD1 ND2 REMARK 470 GLU B 111 CD OE1 OE2 REMARK 470 LYS B 155 CD CE NZ REMARK 470 GLN B 169 CG CD OE1 NE2 REMARK 470 LYS B 303 NZ REMARK 470 GLU B 388 CG CD OE1 OE2 REMARK 470 LYS B 466 CG CD CE NZ REMARK 470 GLN B 497 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN B 19 C1 NAG D 1 1.80 REMARK 500 O4 NAG D 2 O5 BMA D 3 1.84 REMARK 500 O4 NAG C 2 O5 BMA C 3 1.88 REMARK 500 O HOH A 2284 O HOH A 2319 2.05 REMARK 500 O4 NAG C 1 O5 NAG C 2 2.06 REMARK 500 O HOH A 2045 O HOH A 2277 2.08 REMARK 500 O4 NAG D 1 O5 NAG D 2 2.09 REMARK 500 O3 NAG D 1 C1 FUC B 1501 2.10 REMARK 500 O HOH A 2112 O HOH B 2238 2.13 REMARK 500 O HOH A 2027 O HOH A 2029 2.17 REMARK 500 O HOH A 2003 O HOH A 2110 2.19 REMARK 500 O HOH A 2243 O HOH A 2283 2.19 REMARK 500 O HOH B 2069 O HOH B 2314 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE B 26 CB PHE B 26 CG -0.104 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 47 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 ARG A 433 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG B 47 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 47 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 353 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B 433 NE - CZ - NH2 ANGL. DEV. = 4.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 33 -151.25 -65.85 REMARK 500 MET A 49 49.03 38.80 REMARK 500 PHE A 75 -136.77 -117.83 REMARK 500 ALA A 124 -152.10 74.83 REMARK 500 LEU A 156 -71.04 -108.46 REMARK 500 ASN A 192 -168.83 -119.18 REMARK 500 GLU A 233 140.33 -179.72 REMARK 500 GLU A 235 64.84 38.62 REMARK 500 LEU A 249 107.06 -164.52 REMARK 500 LEU A 281 -82.25 75.94 REMARK 500 THR A 323 -73.42 -117.27 REMARK 500 HIS A 374 8.66 84.76 REMARK 500 TRP A 381 -138.25 -86.76 REMARK 500 TYR A 487 -12.93 71.47 REMARK 500 ASN B 19 -155.27 -148.98 REMARK 500 PHE B 75 -132.02 -114.43 REMARK 500 ALA B 124 -154.07 64.48 REMARK 500 LEU B 156 -67.17 -109.63 REMARK 500 ASN B 192 -167.26 -121.16 REMARK 500 GLU B 233 138.59 177.11 REMARK 500 LEU B 249 113.37 -161.61 REMARK 500 ASP B 263 -63.59 -123.93 REMARK 500 LEU B 281 -82.76 74.73 REMARK 500 THR B 323 -70.83 -115.83 REMARK 500 TRP B 381 -134.69 -85.67 REMARK 500 ASN B 392 117.16 -165.21 REMARK 500 ALA B 476 10.10 59.32 REMARK 500 TYR B 487 -14.13 75.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 34 GLY A 35 -47.44 REMARK 500 LEU B 34 GLY B 35 -149.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2044 DISTANCE = 5.88 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 N'-OCTYL(CYCLIC GUANIDINE)-NOJIRIMYCIN (MT5): ALIPHATIC REMARK 600 TAIL IS INVISIBLE IN ELECTRON DENSITY AND, THEREFORE, IS REMARK 600 ABSENT FROM THE STRUCTURE REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG D 1 REMARK 610 FUC A 1502 REMARK 610 MT5 A 1509 REMARK 610 FUC B 1501 REMARK 610 MT5 B 1508 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AC", "BC" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 999 REMARK 999 SEQUENCE REMARK 999 TWO ADDITIONAL AMINO ACIDS AT THE N-TERMINAL (EF) AND SIX REMARK 999 AMINO ACIDS AT THE C-TERMINAL (LLVDTM) DBREF 2WCG A -1 0 PDB 2WCG 2WCG -1 0 DBREF 2WCG A 1 497 UNP B2R6A7 B2R6A7_HUMAN 40 536 DBREF 2WCG A 498 503 PDB 2WCG 2WCG 498 503 DBREF 2WCG B -1 0 PDB 2WCG 2WCG -1 0 DBREF 2WCG B 1 497 UNP B2R6A7 B2R6A7_HUMAN 40 536 DBREF 2WCG B 498 503 PDB 2WCG 2WCG 498 503 SEQRES 1 A 505 GLU PHE ALA ARG PRO CYS ILE PRO LYS SER PHE GLY TYR SEQRES 2 A 505 SER SER VAL VAL CYS VAL CYS ASN ALA THR TYR CYS ASP SEQRES 3 A 505 SER PHE ASP PRO PRO THR PHE PRO ALA LEU GLY THR PHE SEQRES 4 A 505 SER ARG TYR GLU SER THR ARG SER GLY ARG ARG MET GLU SEQRES 5 A 505 LEU SER MET GLY PRO ILE GLN ALA ASN HIS THR GLY THR SEQRES 6 A 505 GLY LEU LEU LEU THR LEU GLN PRO GLU GLN LYS PHE GLN SEQRES 7 A 505 LYS VAL LYS GLY PHE GLY GLY ALA MET THR ASP ALA ALA SEQRES 8 A 505 ALA LEU ASN ILE LEU ALA LEU SER PRO PRO ALA GLN ASN SEQRES 9 A 505 LEU LEU LEU LYS SER TYR PHE SER GLU GLU GLY ILE GLY SEQRES 10 A 505 TYR ASN ILE ILE ARG VAL PRO MET ALA SER CYS ASP PHE SEQRES 11 A 505 SER ILE ARG THR TYR THR TYR ALA ASP THR PRO ASP ASP SEQRES 12 A 505 PHE GLN LEU HIS ASN PHE SER LEU PRO GLU GLU ASP THR SEQRES 13 A 505 LYS LEU LYS ILE PRO LEU ILE HIS ARG ALA LEU GLN LEU SEQRES 14 A 505 ALA GLN ARG PRO VAL SER LEU LEU ALA SER PRO TRP THR SEQRES 15 A 505 SER PRO THR TRP LEU LYS THR ASN GLY ALA VAL ASN GLY SEQRES 16 A 505 LYS GLY SER LEU LYS GLY GLN PRO GLY ASP ILE TYR HIS SEQRES 17 A 505 GLN THR TRP ALA ARG TYR PHE VAL LYS PHE LEU ASP ALA SEQRES 18 A 505 TYR ALA GLU HIS LYS LEU GLN PHE TRP ALA VAL THR ALA SEQRES 19 A 505 GLU ASN GLU PRO SER ALA GLY LEU LEU SER GLY TYR PRO SEQRES 20 A 505 PHE GLN CYS LEU GLY PHE THR PRO GLU HIS GLN ARG ASP SEQRES 21 A 505 PHE ILE ALA ARG ASP LEU GLY PRO THR LEU ALA ASN SER SEQRES 22 A 505 THR HIS HIS ASN VAL ARG LEU LEU MET LEU ASP ASP GLN SEQRES 23 A 505 ARG LEU LEU LEU PRO HIS TRP ALA LYS VAL VAL LEU THR SEQRES 24 A 505 ASP PRO GLU ALA ALA LYS TYR VAL HIS GLY ILE ALA VAL SEQRES 25 A 505 HIS TRP TYR LEU ASP PHE LEU ALA PRO ALA LYS ALA THR SEQRES 26 A 505 LEU GLY GLU THR HIS ARG LEU PHE PRO ASN THR MET LEU SEQRES 27 A 505 PHE ALA SER GLU ALA CYS VAL GLY SER LYS PHE TRP GLU SEQRES 28 A 505 GLN SER VAL ARG LEU GLY SER TRP ASP ARG GLY MET GLN SEQRES 29 A 505 TYR SER HIS SER ILE ILE THR ASN LEU LEU TYR HIS VAL SEQRES 30 A 505 VAL GLY TRP THR ASP TRP ASN LEU ALA LEU ASN PRO GLU SEQRES 31 A 505 GLY GLY PRO ASN TRP VAL ARG ASN PHE VAL ASP SER PRO SEQRES 32 A 505 ILE ILE VAL ASP ILE THR LYS ASP THR PHE TYR LYS GLN SEQRES 33 A 505 PRO MET PHE TYR HIS LEU GLY HIS PHE SER LYS PHE ILE SEQRES 34 A 505 PRO GLU GLY SER GLN ARG VAL GLY LEU VAL ALA SER GLN SEQRES 35 A 505 LYS ASN ASP LEU ASP ALA VAL ALA LEU MET HIS PRO ASP SEQRES 36 A 505 GLY SER ALA VAL VAL VAL VAL LEU ASN ARG SER SER LYS SEQRES 37 A 505 ASP VAL PRO LEU THR ILE LYS ASP PRO ALA VAL GLY PHE SEQRES 38 A 505 LEU GLU THR ILE SER PRO GLY TYR SER ILE HIS THR TYR SEQRES 39 A 505 LEU TRP HIS ARG GLN LEU LEU VAL ASP THR MET SEQRES 1 B 505 GLU PHE ALA ARG PRO CYS ILE PRO LYS SER PHE GLY TYR SEQRES 2 B 505 SER SER VAL VAL CYS VAL CYS ASN ALA THR TYR CYS ASP SEQRES 3 B 505 SER PHE ASP PRO PRO THR PHE PRO ALA LEU GLY THR PHE SEQRES 4 B 505 SER ARG TYR GLU SER THR ARG SER GLY ARG ARG MET GLU SEQRES 5 B 505 LEU SER MET GLY PRO ILE GLN ALA ASN HIS THR GLY THR SEQRES 6 B 505 GLY LEU LEU LEU THR LEU GLN PRO GLU GLN LYS PHE GLN SEQRES 7 B 505 LYS VAL LYS GLY PHE GLY GLY ALA MET THR ASP ALA ALA SEQRES 8 B 505 ALA LEU ASN ILE LEU ALA LEU SER PRO PRO ALA GLN ASN SEQRES 9 B 505 LEU LEU LEU LYS SER TYR PHE SER GLU GLU GLY ILE GLY SEQRES 10 B 505 TYR ASN ILE ILE ARG VAL PRO MET ALA SER CYS ASP PHE SEQRES 11 B 505 SER ILE ARG THR TYR THR TYR ALA ASP THR PRO ASP ASP SEQRES 12 B 505 PHE GLN LEU HIS ASN PHE SER LEU PRO GLU GLU ASP THR SEQRES 13 B 505 LYS LEU LYS ILE PRO LEU ILE HIS ARG ALA LEU GLN LEU SEQRES 14 B 505 ALA GLN ARG PRO VAL SER LEU LEU ALA SER PRO TRP THR SEQRES 15 B 505 SER PRO THR TRP LEU LYS THR ASN GLY ALA VAL ASN GLY SEQRES 16 B 505 LYS GLY SER LEU LYS GLY GLN PRO GLY ASP ILE TYR HIS SEQRES 17 B 505 GLN THR TRP ALA ARG TYR PHE VAL LYS PHE LEU ASP ALA SEQRES 18 B 505 TYR ALA GLU HIS LYS LEU GLN PHE TRP ALA VAL THR ALA SEQRES 19 B 505 GLU ASN GLU PRO SER ALA GLY LEU LEU SER GLY TYR PRO SEQRES 20 B 505 PHE GLN CYS LEU GLY PHE THR PRO GLU HIS GLN ARG ASP SEQRES 21 B 505 PHE ILE ALA ARG ASP LEU GLY PRO THR LEU ALA ASN SER SEQRES 22 B 505 THR HIS HIS ASN VAL ARG LEU LEU MET LEU ASP ASP GLN SEQRES 23 B 505 ARG LEU LEU LEU PRO HIS TRP ALA LYS VAL VAL LEU THR SEQRES 24 B 505 ASP PRO GLU ALA ALA LYS TYR VAL HIS GLY ILE ALA VAL SEQRES 25 B 505 HIS TRP TYR LEU ASP PHE LEU ALA PRO ALA LYS ALA THR SEQRES 26 B 505 LEU GLY GLU THR HIS ARG LEU PHE PRO ASN THR MET LEU SEQRES 27 B 505 PHE ALA SER GLU ALA CYS VAL GLY SER LYS PHE TRP GLU SEQRES 28 B 505 GLN SER VAL ARG LEU GLY SER TRP ASP ARG GLY MET GLN SEQRES 29 B 505 TYR SER HIS SER ILE ILE THR ASN LEU LEU TYR HIS VAL SEQRES 30 B 505 VAL GLY TRP THR ASP TRP ASN LEU ALA LEU ASN PRO GLU SEQRES 31 B 505 GLY GLY PRO ASN TRP VAL ARG ASN PHE VAL ASP SER PRO SEQRES 32 B 505 ILE ILE VAL ASP ILE THR LYS ASP THR PHE TYR LYS GLN SEQRES 33 B 505 PRO MET PHE TYR HIS LEU GLY HIS PHE SER LYS PHE ILE SEQRES 34 B 505 PRO GLU GLY SER GLN ARG VAL GLY LEU VAL ALA SER GLN SEQRES 35 B 505 LYS ASN ASP LEU ASP ALA VAL ALA LEU MET HIS PRO ASP SEQRES 36 B 505 GLY SER ALA VAL VAL VAL VAL LEU ASN ARG SER SER LYS SEQRES 37 B 505 ASP VAL PRO LEU THR ILE LYS ASP PRO ALA VAL GLY PHE SEQRES 38 B 505 LEU GLU THR ILE SER PRO GLY TYR SER ILE HIS THR TYR SEQRES 39 B 505 LEU TRP HIS ARG GLN LEU LEU VAL ASP THR MET MODRES 2WCG ASN A 19 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET FUC A1502 10 HET SO4 A1503 5 HET SO4 A1504 5 HET SO4 A1505 5 HET SO4 A1506 5 HET SO4 A1507 5 HET SO4 A1508 5 HET MT5 A1509 14 HET CL A1510 1 HET FUC B1501 10 HET SO4 B1502 5 HET SO4 B1503 5 HET SO4 B1504 5 HET SO4 B1505 5 HET SO4 B1506 5 HET SO4 B1507 5 HET MT5 B1508 14 HET CL B1509 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM MT5 N-[(3E,5R,6R,7S,8R,8AR)-5,6,7,8- HETNAM 2 MT5 TETRAHYDROXYHEXAHYDROIMIDAZO[1,5-A]PYRIDIN-3(2H)- HETNAM 3 MT5 YLIDENE]OCTAN-1-AMINIUM HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 5 FUC 2(C6 H12 O5) FORMUL 6 SO4 12(O4 S 2-) FORMUL 12 MT5 2(C15 H30 N3 O4 1+) FORMUL 13 CL 2(CL 1-) FORMUL 23 HOH *741(H2 O) HELIX 1 1 THR A 86 LEU A 94 1 9 HELIX 2 2 SER A 97 SER A 110 1 14 HELIX 3 3 PRO A 150 LYS A 155 1 6 HELIX 4 4 LEU A 156 ALA A 168 1 13 HELIX 5 5 PRO A 182 LEU A 185 5 4 HELIX 6 6 ASP A 203 GLU A 222 1 20 HELIX 7 7 SER A 237 LEU A 241 5 5 HELIX 8 8 THR A 252 ASP A 263 1 12 HELIX 9 9 ASP A 263 ASN A 270 1 8 HELIX 10 10 LEU A 286 LEU A 288 5 3 HELIX 11 11 PRO A 289 THR A 297 1 9 HELIX 12 12 ASP A 298 LYS A 303 1 6 HELIX 13 13 LEU A 314 ALA A 318 5 5 HELIX 14 14 PRO A 319 PHE A 331 1 13 HELIX 15 15 SER A 356 TYR A 373 1 18 HELIX 16 16 ILE A 406 ASP A 409 5 4 HELIX 17 17 GLN A 414 LYS A 425 1 12 HELIX 18 18 THR B 86 LEU B 94 1 9 HELIX 19 19 SER B 97 SER B 110 1 14 HELIX 20 20 PRO B 150 LYS B 155 1 6 HELIX 21 21 LEU B 156 ALA B 168 1 13 HELIX 22 22 PRO B 182 LEU B 185 5 4 HELIX 23 23 ASP B 203 GLU B 222 1 20 HELIX 24 24 SER B 237 LEU B 241 5 5 HELIX 25 25 THR B 252 ASP B 263 1 12 HELIX 26 26 ASP B 263 ASN B 270 1 8 HELIX 27 27 LEU B 286 LEU B 288 5 3 HELIX 28 28 PRO B 289 THR B 297 1 9 HELIX 29 29 ASP B 298 LYS B 303 1 6 HELIX 30 30 LEU B 314 ALA B 318 5 5 HELIX 31 31 PRO B 319 PHE B 331 1 13 HELIX 32 32 SER B 356 TYR B 373 1 18 HELIX 33 33 ILE B 406 ASP B 409 5 4 HELIX 34 34 GLN B 414 LYS B 425 1 12 SHEET 1 AA 4 PRO A 6 LYS A 7 0 SHEET 2 AA 4 VAL A 15 CYS A 18 -1 O VAL A 15 N LYS A 7 SHEET 3 AA 4 THR A 410 LYS A 413 -1 O PHE A 411 N CYS A 18 SHEET 4 AA 4 ILE A 402 ASP A 405 -1 O ILE A 403 N TYR A 412 SHEET 1 AB 9 GLU A 50 PRO A 55 0 SHEET 2 AB 9 THR A 36 SER A 42 -1 O PHE A 37 N GLY A 54 SHEET 3 AB 9 ILE A 489 TRP A 494 -1 O ILE A 489 N SER A 42 SHEET 4 AB 9 ALA A 456 ASN A 462 -1 O ALA A 456 N TRP A 494 SHEET 5 AB 9 LEU A 444 MET A 450 -1 O ASP A 445 N LEU A 461 SHEET 6 AB 9 GLN A 432 ALA A 438 -1 O GLN A 432 N MET A 450 SHEET 7 AB 9 LEU A 65 LYS A 77 -1 O THR A 68 N VAL A 437 SHEET 8 AB 9 VAL A 468 ASP A 474 1 O PRO A 469 N LEU A 65 SHEET 9 AB 9 GLY A 478 SER A 484 -1 O GLY A 478 N ASP A 474 SHEET 1 AC 9 GLY A 80 ALA A 84 0 SHEET 2 AC 9 VAL A 375 ASN A 382 1 O TRP A 378 N GLY A 82 SHEET 3 AC 9 MET A 335 GLU A 340 1 O LEU A 336 N VAL A 376 SHEET 4 AC 9 GLY A 307 HIS A 311 1 O ILE A 308 N PHE A 337 SHEET 5 AC 9 ARG A 277 GLN A 284 1 O MET A 280 N ALA A 309 SHEET 6 AC 9 ALA A 229 THR A 231 1 O VAL A 230 N LEU A 279 SHEET 7 AC 9 SER A 173 PRO A 178 1 O ALA A 176 N THR A 231 SHEET 8 AC 9 ILE A 118 MET A 123 1 O ILE A 119 N LEU A 175 SHEET 9 AC 9 GLY A 80 ALA A 84 1 O GLY A 83 N ARG A 120 SHEET 1 BA 4 PRO B 6 LYS B 7 0 SHEET 2 BA 4 VAL B 15 CYS B 18 -1 O VAL B 15 N LYS B 7 SHEET 3 BA 4 THR B 410 LYS B 413 -1 O PHE B 411 N CYS B 18 SHEET 4 BA 4 ILE B 402 ASP B 405 -1 O ILE B 403 N TYR B 412 SHEET 1 BB 9 GLU B 50 PRO B 55 0 SHEET 2 BB 9 THR B 36 SER B 42 -1 O PHE B 37 N GLY B 54 SHEET 3 BB 9 ILE B 489 TRP B 494 -1 O ILE B 489 N SER B 42 SHEET 4 BB 9 ALA B 456 ASN B 462 -1 O ALA B 456 N TRP B 494 SHEET 5 BB 9 LEU B 444 MET B 450 -1 O ASP B 445 N LEU B 461 SHEET 6 BB 9 GLN B 432 ALA B 438 -1 O GLN B 432 N MET B 450 SHEET 7 BB 9 LEU B 66 LYS B 77 -1 O THR B 68 N VAL B 437 SHEET 8 BB 9 VAL B 468 ASP B 474 1 O THR B 471 N LEU B 67 SHEET 9 BB 9 GLY B 478 SER B 484 -1 O GLY B 478 N ASP B 474 SHEET 1 BC 9 GLY B 80 ALA B 84 0 SHEET 2 BC 9 VAL B 375 ASN B 382 1 O TRP B 378 N GLY B 82 SHEET 3 BC 9 MET B 335 GLU B 340 1 O LEU B 336 N VAL B 376 SHEET 4 BC 9 GLY B 307 HIS B 311 1 O ILE B 308 N PHE B 337 SHEET 5 BC 9 ARG B 277 GLN B 284 1 O MET B 280 N ALA B 309 SHEET 6 BC 9 ALA B 229 THR B 231 1 O VAL B 230 N LEU B 279 SHEET 7 BC 9 SER B 173 PRO B 178 1 O ALA B 176 N THR B 231 SHEET 8 BC 9 ILE B 118 MET B 123 1 O ILE B 119 N LEU B 175 SHEET 9 BC 9 GLY B 80 ALA B 84 1 O GLY B 83 N ARG B 120 SSBOND 1 CYS A 4 CYS A 16 1555 1555 2.10 SSBOND 2 CYS A 18 CYS A 23 1555 1555 2.20 SSBOND 3 CYS B 4 CYS B 16 1555 1555 2.12 SSBOND 4 CYS B 18 CYS B 23 1555 1555 2.22 LINK ND2 ASN A 19 C1 NAG C 1 1555 1555 1.79 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.08 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.38 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.06 CISPEP 1 LEU A 288 PRO A 289 0 5.98 CISPEP 2 GLY A 390 PRO A 391 0 -2.49 CISPEP 3 LEU B 288 PRO B 289 0 5.33 CISPEP 4 GLY B 390 PRO B 391 0 1.62 CRYST1 68.311 96.827 83.234 90.00 104.34 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014639 0.000000 0.003742 0.00000 SCALE2 0.000000 0.010328 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012401 0.00000